SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 17 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Granite Point Capital Management, L.P. | 105,261 | $954,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,450 | $1,813,000 | 0.30% |
| LANSDOWNE PARTNERS (UK) LLP | 930,000 | $8,430,000 | 0.07% |
| Point72 Asset Management, L.P. | 926,199 | $8,395,000 | 0.06% |
| AXA S.A. | 383,054 | $3,472,000 | 0.02% |
| First Eagle Investment Management, LLC | 175,000 | $1,607,000 | 0.00% |
| Jacobi Capital Management LLC | 500 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,213 | $11,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
| UBS Group AG | 1,340 | $12,000 | 0.00% |